WASHINGTON (AP) — WASHINGTON (AP) — Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $62.5 million in its second quarter.
On a per-share basis, the Washington-based company said it had a loss of $1.04.
The biopharmaceutical company posted revenue of $50.5 million in the period.
Vanda expects full-year revenue in the range of $240 million to $290 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA
